Medical News

RSS
Pharma in Asia-Pacific region becomes more active in R&D, study finds

Pharma in Asia-Pacific region becomes more active in R&D, study finds

Regulus receives $488,989 grant under QTDP program

Regulus receives $488,989 grant under QTDP program

New simple blood test may help diagnose Niemann-Pick type C disease

New simple blood test may help diagnose Niemann-Pick type C disease

Idaho seeks FDA marketing clearance for FilmArray Respiratory Panel

Idaho seeks FDA marketing clearance for FilmArray Respiratory Panel

The GOP scores big wins in mid-term elections

The GOP scores big wins in mid-term elections

New laparoscopic instrument mimics human index finger

New laparoscopic instrument mimics human index finger

Alnylam third quarter revenue increases from $24.2 million to $27.7 million

Alnylam third quarter revenue increases from $24.2 million to $27.7 million

Today's Op-Eds: What the GOP can do with 'Obamacare' and more about the doctor shortage

Today's Op-Eds: What the GOP can do with 'Obamacare' and more about the doctor shortage

Cerebral palsy risk doubles with IVF: Study

Cerebral palsy risk doubles with IVF: Study

Collapsing with laughter: Literally

Collapsing with laughter: Literally

Workers unwilling to disclose work related stress: Survey

Workers unwilling to disclose work related stress: Survey

Eye implant restores some vision in retinitis pigmentosa

Eye implant restores some vision in retinitis pigmentosa

One-third of breast cancer survivors rate breast-conserving treatments as fair

One-third of breast cancer survivors rate breast-conserving treatments as fair

Vanda third quarter total revenue increases to $7.2 million

Vanda third quarter total revenue increases to $7.2 million

Bortezomib reduces inflammation and promotes bone healing in arthritis models

Bortezomib reduces inflammation and promotes bone healing in arthritis models

Insmed third quarter total revenues decrease to $1.8 million

Insmed third quarter total revenues decrease to $1.8 million

ADVENTRX submits NDA for Exelbine to FDA

ADVENTRX submits NDA for Exelbine to FDA

BioClinica third quarter service revenues increase to $15.8 million

BioClinica third quarter service revenues increase to $15.8 million

First Edition: November 3, 2010

First Edition: November 3, 2010

Cambridge Heart third quarter sales increase 21% to $793,000

Cambridge Heart third quarter sales increase 21% to $793,000

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.